These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Changes in the clinicopathological characteristics and genetic alterations of follicular thyroid cancer. Song YS, Lim JA, Min HS, Kim MJ, Choi HS, Cho SW, Moon JH, Yi KH, Park DJ, Cho BY, Park YJ. Eur J Endocrinol; 2017 Dec; 177(6):465-473. PubMed ID: 28864536 [Abstract] [Full Text] [Related]
6. Clinical utility of EZH1 mutations in the diagnosis of follicular-patterned thyroid tumors. Jung CK, Kim Y, Jeon S, Jo K, Lee S, Bae JS. Hum Pathol; 2018 Nov; 81():9-17. PubMed ID: 29723601 [Abstract] [Full Text] [Related]
7. Highly Concordant Key Genetic Alterations in Primary Tumors and Matched Distant Metastases in Differentiated Thyroid Cancer. Sohn SY, Park WY, Shin HT, Bae JS, Ki CS, Oh YL, Kim SW, Chung JH. Thyroid; 2016 May; 26(5):672-82. PubMed ID: 26971368 [Abstract] [Full Text] [Related]
8. BRAF and RAS Mutational Status in Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features and Invasive Subtype of Encapsulated Follicular Variant of Papillary Thyroid Carcinoma in Korea. Kim M, Jeon MJ, Oh HS, Park S, Kim TY, Shong YK, Kim WB, Kim K, Kim WG, Song DE. Thyroid; 2018 Apr; 28(4):504-510. PubMed ID: 29439609 [Abstract] [Full Text] [Related]
11. The histologic outcomes of indeterminate thyroid nodules with rat sarcoma mutations: A case series. Jones M, Abendano DG, Turner M, Sullivan C, Reyes MCD. Diagn Cytopathol; 2023 Dec; 51(12):E332-E337. PubMed ID: 37583345 [Abstract] [Full Text] [Related]
12. Single Point Mutations in Pediatric Differentiated Thyroid Cancer. Alzahrani AS, Murugan AK, Qasem E, Alswailem M, Al-Hindi H, Shi Y. Thyroid; 2017 Feb; 27(2):189-196. PubMed ID: 27824297 [Abstract] [Full Text] [Related]
14. Mutational burdens and evolutionary ages of thyroid follicular adenoma are comparable to those of follicular carcinoma. Jung SH, Kim MS, Jung CK, Park HC, Kim SY, Liu J, Bae JS, Lee SH, Kim TM, Lee SH, Chung YJ. Oncotarget; 2016 Oct 25; 7(43):69638-69648. PubMed ID: 27626165 [Abstract] [Full Text] [Related]
15. Genotyping of an Italian papillary thyroid carcinoma cohort revealed high prevalence of BRAF mutations, absence of RAS mutations and allowed the detection of a new mutation of BRAF oncoprotein (BRAF(V599lns)). Carta C, Moretti S, Passeri L, Barbi F, Avenia N, Cavaliere A, Monacelli M, Macchiarulo A, Santeusanio F, Tartaglia M, Puxeddu E. Clin Endocrinol (Oxf); 2006 Jan 25; 64(1):105-9. PubMed ID: 16402937 [Abstract] [Full Text] [Related]
18. Thyroid nodules with KRAS mutations are different from nodules with NRAS and HRAS mutations with regard to cytopathologic and histopathologic outcome characteristics. Radkay LA, Chiosea SI, Seethala RR, Hodak SP, LeBeau SO, Yip L, McCoy KL, Carty SE, Schoedel KE, Nikiforova MN, Nikiforov YE, Ohori NP. Cancer Cytopathol; 2014 Dec 25; 122(12):873-82. PubMed ID: 25132659 [Abstract] [Full Text] [Related]
19. Mutational screening of RET, HRAS, KRAS, NRAS, BRAF, AKT1, and CTNNB1 in medullary thyroid carcinoma. Schulten HJ, Al-Maghrabi J, Al-Ghamdi K, Salama S, Al-Muhayawi S, Chaudhary A, Hamour O, Abuzenadah A, Gari M, Al-Qahtani M. Anticancer Res; 2011 Dec 25; 31(12):4179-83. PubMed ID: 22199277 [Abstract] [Full Text] [Related]
20. Differences in Mutational Profile between Follicular Thyroid Carcinoma and Follicular Thyroid Adenoma Identified Using Next Generation Sequencing. Borowczyk M, Szczepanek-Parulska E, Dębicki S, Budny B, Verburg FA, Filipowicz D, Więckowska B, Janicka-Jedyńska M, Gil L, Ziemnicka K, Ruchała M. Int J Mol Sci; 2019 Jun 26; 20(13):. PubMed ID: 31248021 [Abstract] [Full Text] [Related] Page: [Next] [New Search]